Question: is alnylam a good investment?
Answer: Preliminary data is highly positive. In March, Vir and Alnylam expanded their collaboration to find an RNAi drug to combat COVID-19. Without any profits, and with a price-to-sales ratio of 53, Alnylam has to be called an expensive investment right now.